Announcement on Voluntary Disclosure of the First Subject Dosing in the Phase I Clinical Trial of EP-0226 Tablets
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment